New England Journal of Medicine Retracts Amgen Drug Trial Paper Over Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant clinical trial paper that supported the use of Amgen’s drug Tavneos. The retraction follows concerns raised about the integrity of the patient outcome data used in the study, with allegations that the data were altered and that some researchers involved in the trial were […]